Eli Lilly and Company
Lilly and Hims & Hers expand access to Zepbound and Foundayo
Eli Lilly and Hims & Hers have agreed to expand access to Lilly’s FDA-approved obesity medicines Zepbound and Foundayo through the Hims & Hers platform. Eligible…
Eli Lilly Licenses Largest Speech Dataset for Alzheimer's Research
Eli Lilly and Company has licensed SpeechDx, the Alzheimer's Drug Discovery Foundation's dataset of speech and biomarker data, to study whether speech can serve as a…
Mediar Completes Enrollment in Phase 2 WISPer Trial of MTX-463 for IPF
Mediar Therapeutics has completed enrollment in its Phase 2 WISPer study of MTX-463, a first-in-class antibody for idiopathic pulmonary fibrosis (IPF), with 168 patients…
General Medicine Raises $120 Million Series B for Online Healthcare Store
General Medicine, a San Francisco company that runs a nationwide healthcare store, has raised $120 million in Series B financing led by Andreessen Horowitz (a16z). The…
insitro and Lilly Bring In Vivo Drug Property Prediction Models to TuneLab
Machine learning models that insitro built with Eli Lilly to predict in vitro and in vivo properties of small molecules are now available to certain biotech companies…